Chemical formula: C₁₄H₃₀N₂O₄+₂ Molecular mass: 290.399 g/mol PubChem compound: 5314
Suxamethonium is a short-acting depolarising neuromuscular blocking agent. Suxamethonium inhibits neuromuscular transmission by depolarising the motor end plates in skeletal muscle.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M03AB01 | Suxamethonium | M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AB Choline derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| SUXAMETHONIUM CHLORIDE Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| QUELICIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Suxamethonium is an active ingredient of these brands:
Austria (AT)
Brazil (BR)
Canada (CA)
Estonia (EE)
Finland (FI)
France (FR)
Japan (JP)
Lithuania (LT)
Malta (MT)
Romania (RO)
Singapore (SG)
Spain (ES)
Turkey (TR)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
